Biogen BIIB
NASDAQ BIIB
$215.50 -3.55 (-1.62%)
At close: Sep 18, 2026 · 4:00 PM EDT

Biogen (BIIB) Other Non Operating Income (2009 - 2015)

Biogen (BIIB) posted Other Non Operating Income of -$15.0 million for Q1 2015, down 70.88% on a QoQ basis from -$8.8 million in Q4 2014, and down 167.56% year-over-year from $22.2 million in Q1 2014.

Analysis

Biogen (BIIB) Other Non Operating Income (2009 - 2015) Analysis & Trends

Biogen has reported Other Non Operating Income for 7 years, with the latest figure at -$15.0 million in Q1 2015.

  • On a quarterly basis, Other Non Operating Income fell 167.56% year-over-year to -$15.0 million in Q1 2015; TTM through Mar 2015 was -$35.2 million, a 35.1% decrease from a year earlier, with the FY2016 full-year figure at -$217.4 million, down 75.75% from the prior year.
  • Other Non Operating Income was -$15.0 million for Q1 2015 at Biogen, down from -$8.8 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $15.1 million in Q1 2012, with the low at -$17.4 million in Q1 2011.
  • Average Other Non Operating Income over 5 years is -$6.2 million, with a median of -$5.6 million recorded in 2014.
  • The sharpest annual moves came in 2012 and 2013: Other Non Operating Income jumped 73850.0% in 2012, then tumbled 453.49% in 2013.
  • Over 5 years, Other Non Operating Income stood at -$4.0 million in 2011, then plunged by 259.68% to -$14.3 million in 2012, then surged by 62.39% to -$5.4 million in 2013, then plunged by 63.16% to -$8.8 million in 2014, then slumped by 70.88% to -$15.0 million in 2015.
  • The last three Other Non Operating Income figures came in at -$15.0 million (Q1 2015), -$8.8 million (Q4 2014), and -$16.3 million (Q3 2014), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn
10 Insmed 26.19 Bn 25.03 Bn 358.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 -14.99 Mn
Dec 31, 2014 -8.77 Mn
Sep 30, 2014 -16.29 Mn
Jun 30, 2014 4.86 Mn
Mar 31, 2014 -5.60 Mn
Dec 31, 2013 -5.38 Mn
Sep 30, 2013 -4.64 Mn
Jun 30, 2013 -10.43 Mn
Mar 31, 2013 -14.46 Mn
Dec 31, 2012 -14.29 Mn
Sep 30, 2012 -4.55 Mn
Jun 30, 2012 2.95 Mn
Mar 31, 2012 15.14 Mn
Dec 31, 2011 -3.97 Mn
Sep 30, 2011 -7.73 Mn
Jun 30, 2011 -4,000.00
Mar 31, 2011 -17.38 Mn
Dec 31, 2010 -4.70 Mn
Sep 30, 2010 -6.90 Mn
Jun 30, 2010 1.00 Mn